Home > News News

News and Press Releases

Read Veristat news and press releases to learn about our CRO service growth, geographic expansion in Europe and Asia, biotechnology preferred partnerships and small CRO acquisitions.

Veristat and AOBiome Therapeutics to Present at Clinical Outsourcing Group on Essential Elements of Effective Partnerships with CROs

Southborough, MA - Oct. 7, 2025 – Veristat, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced today that it will participate in the Clinical Outsourcing Group – Bay Area 2025 conference, taking place October 21-22, 2025 at the Hyatt Regency San Francisco Airport, Burlingame, CA. Veristat is speaking with AOBiome Therapeutics, a clinical-stage biotech company focusing on inflammatory conditions, on October 21 at 4:45 p.m. PT and will address how early integration and honest, sometimes difficult conversations between sponsors and CROs can improve trial success.

Cook MyoSite and Veristat Partner in Complex, Phase III, Adaptive Clinical Study of...

Veristat partners to achieve key enrollment milestone for study; activated 26 sites and enrolled over 100 participants

Veristat Achieves EcoVadis Committed Badge: A Milestone in Our Sustainability Journey

We're proud to announce that Veristat has received our first EcoVadis Committed Badge, marking a significant milestone in our commitment to...

Veristat Congratulates George Medicines on FDA Approval of WIDAPLIK™

Proud to Collaborate in Delivering a Groundbreaking, First-in-Class Therapy to Patients in Need

Veristat Appoints Industry Veteran Kim McLean Boericke as its Chief Operating Officer

Accelerating Operational Excellence and Client Success

SOUTHBOROUGH, MA – October 30, 2024—Veristat, a scientific-minded global clinical...

Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team

To support sponsors around the globe bringing novel treatments to patients

SOUTHBOROUGH, MA – May 29, 2024 – Veristat, the Science-First...

Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues...

Committed  to a Science-First Approach to Support Patient Access to Life-Changing Therapies

Veristat Acquires Biometrics-focused Instat Clinical Research

Acquisition Will Power Data insights, Trial Optimization, and Value Across Clinical Development  

Veristat Acquires European Medical Writing Consultancy Scinopsis

Expands Medical Writing Team, Helping Sponsors Communicate the Value of Their Data Globally